Embedded Files
About Portis
About Portis
Portis Clinical Trials is a UK clinical operations company that runs trial sites outside the hospital setting, with a focus on Phase III studies for pharmaceutical sponsors.
Our sites are based in primary care. They combine access to large registered patient populations with dedicated research teams, including research nurses, clinical trials pharmacists and principal investigators, supported by external laboratory partners. We identify, recruit and manage eligible patients directly from these populations, and our teams and infrastructure deliver complex, multi-year trials to the standards commercial sponsors expect.
Access to clinical trials
Access to clinical trials
Most clinical trials are run from hospitals, so many patients are never offered the chance to take part. This is especially true for people whose care is managed by their GP, those who live far from a research hospital, and those who find hospital visits difficult.
Portis runs trials in primary care, where patients already receive most of their care. Patients are approached by a practice they know, and their study visits take place locally. This gives more patients the opportunity to take part in research and helps trial populations better reflect the people who will use new treatments.
What we do for sponsors
What we do for sponsors
Portis manages the full site process, including feasibility, regulatory approvals, contracting, patient identification and visit delivery. Our sites can support hybrid trial designs, combining in-person visits close to patients’ homes with remote elements where the trial design allows.
We are building a group of sites working to the same standard processes, so that sponsors can place a substantial part of their UK recruitment with a single partner. Our aim is to give sponsors confidence that recruitment targets will be met on time.
Leadership
Leadership
Liba Stones, Founder and CEO
Liba Stones has 20 years of clinical research experience. She was Head of R&D at the Royal Free, King’s College, Cumbria Partnership, and Barnet and Chase Farm, and Clinical Trials Programme Manager at the Institute of Cancer Research, where she oversaw a programme of breast cancer radiotherapy trials. At UCB Pharma, she worked in Global Clinical Sciences & Operations Innovation, where she led the implementation of decentralised trial technologies, such as eConsent, in international studies.
She has also designed and led trials of digital health technologies, and through Carola Consulting she advises digital health companies on trial design, regulatory pathways and clinical safety. She has co-authored publications in The Lancet, Trials and a Nature portfolio journal, including work on patient and public involvement in research.
Contact
Contact
For sponsor enquiries and site partnerships, please contact liba@portistrials.com.
Page updated
Report abuse